Research Article

Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor Prognostic Markers in Gastric Adenocarcinoma

Table 3

KEGG pathway analysis of differentially expressed genes in gastric adenocarcinoma.

ExpressionTermCount%-valueGenes

Upregulatedptr04512:ECM-receptor interaction525.08.56E − 07COL1A2, COL1A1, THBS2, COL11A1, SPP1
ptr04510:focal adhesion525.02.60E − 05COL1A2, COL1A1, THBS2, COL11A1, SPP1
ptr04974:protein digestion and absorption420.05.98E − 05COL1A2, COL1A1, COL11A1, COL10A1
ptr04151:PI3K-Akt signaling pathway525.01.78E − 04COL1A2, COL1A1, THBS2, COL11A1, SPP1
ptr05146:amoebiasis315.00.004694COL1A2, COL1A1, COL11A1
ptr04611:platelet activation315.00.00728COL1A2, COL1A1, COL11A1

Downregulatedhsa04971:gastric acid secretion612.22.68E − 06KCNJ16, KCNJ15, ATP4A, ATP4B, KCNE2, CA2
hsa00830:retinol metabolism48.20.001043RDH12, CYP2C18, ADH7, UGT2B15
hsa05204:chemical carcinogenesis48.20.001989CYP2C18, ADH7, UGT2B15, ALDH3A1
hsa04966:collecting duct acid secretion36.10.003265ATP4A, ATP4B, CA2
hsa00010:glycolysis/gluconeogenesis36.10.019041ADH7, FBP2, ALDH3A1
hsa00982:drug metabolism—cytochrome P45036.10.019581ADH7, UGT2B15, ALDH3A1
hsa00980:metabolism of xenobiotics by cytochrome P45036.10.022951ADH7, UGT2B15, ALDH3A1
hsa01100:metabolic pathways918.40.029288RDH12, CYP2C18, ACER2, AKR1B10, ADH7, FBP2, UGT2B15, ALDH3A1, LIPF